These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1014 related articles for article (PubMed ID: 17971532)
41. Glioma stem cell signaling: therapeutic opportunities and challenges. Dietrich J; Diamond EL; Kesari S Expert Rev Anticancer Ther; 2010 May; 10(5):709-22. PubMed ID: 20470003 [TBL] [Abstract][Full Text] [Related]
42. Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors. Chan JK; Lam PY Cancer Gene Ther; 2013 Oct; 20(10):539-43. PubMed ID: 24052128 [TBL] [Abstract][Full Text] [Related]
43. Knockdown of annexin 2 decreases migration of human glioma cells in vitro. Tatenhorst L; Rescher U; Gerke V; Paulus W Neuropathol Appl Neurobiol; 2006 Jun; 32(3):271-7. PubMed ID: 16640645 [TBL] [Abstract][Full Text] [Related]
44. Brain slice invasion model reveals genes differentially regulated in glioma invasion. Holtkamp N; Afanasieva A; Elstner A; van Landeghem FK; Könneker M; Kuhn SA; Kettenmann H; von Deimling A Biochem Biophys Res Commun; 2005 Nov; 336(4):1227-33. PubMed ID: 16171788 [TBL] [Abstract][Full Text] [Related]
45. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling. Kim JK; Jin X; Sohn YW; Jin X; Jeon HY; Kim EJ; Ham SW; Jeon HM; Chang SY; Oh SY; Yin J; Kim SH; Park JB; Nakano I; Kim H Cancer Lett; 2014 Oct; 353(2):194-200. PubMed ID: 25079688 [TBL] [Abstract][Full Text] [Related]
46. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor. Shibuya M FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071 [TBL] [Abstract][Full Text] [Related]
47. Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment. Fomchenko EI; Holland EC Neurosurg Clin N Am; 2007 Jan; 18(1):39-58, viii. PubMed ID: 17244553 [TBL] [Abstract][Full Text] [Related]
48. Therapeutic strategies for inhibiting invasion in glioblastoma. Drappatz J; Norden AD; Wen PY Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303 [TBL] [Abstract][Full Text] [Related]
49. Tumor vasculature and glioma stem cells: Contributions to glioma progression. Jhaveri N; Chen TC; Hofman FM Cancer Lett; 2016 Oct; 380(2):545-551. PubMed ID: 25527451 [TBL] [Abstract][Full Text] [Related]
51. Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells. Jurvansuu J; Zhao Y; Leung DS; Boulaire J; Yu YH; Ahmed S; Wang S Cancer Res; 2008 Jun; 68(12):4614-22. PubMed ID: 18559506 [TBL] [Abstract][Full Text] [Related]
52. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Campos B; Wan F; Farhadi M; Ernst A; Zeppernick F; Tagscherer KE; Ahmadi R; Lohr J; Dictus C; Gdynia G; Combs SE; Goidts V; Helmke BM; Eckstein V; Roth W; Beckhove P; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende C Clin Cancer Res; 2010 May; 16(10):2715-28. PubMed ID: 20442299 [TBL] [Abstract][Full Text] [Related]
53. Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis. Winkler F; Kienast Y; Fuhrmann M; Von Baumgarten L; Burgold S; Mitteregger G; Kretzschmar H; Herms J Glia; 2009 Sep; 57(12):1306-15. PubMed ID: 19191326 [TBL] [Abstract][Full Text] [Related]
54. The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells. Florio T; Barbieri F Drug Discov Today; 2012 Oct; 17(19-20):1103-10. PubMed ID: 22704957 [TBL] [Abstract][Full Text] [Related]